These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2840780)

  • 21. [Surgical treatment of intractable ascites].
    Kvist N; Friis J; Nielsen OV
    Ugeskr Laeger; 1983 Sep; 145(38):2926-9. PubMed ID: 6649100
    [No Abstract]   [Full Text] [Related]  

  • 22. Malignant ascites: demographics, therapeutic efficacy and predictors of survival.
    Mackey JR; Venner PM
    Can J Oncol; 1996 Nov; 6(2):474-80. PubMed ID: 12056099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
    Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
    Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenesis and management of refractory malignant ascites].
    Saâda E; Follana P; Peyrade F; Mari V; François E
    Bull Cancer; 2011 Jun; 98(6):679-87. PubMed ID: 21636346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneo-venous shunts for malignant ascites.
    Gough IR
    Aust N Z J Surg; 1982 Feb; 52(1):47-9. PubMed ID: 6951551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of refractory ascites in hemodialysis patient with peritoneovenous shunt (Denver shunt).
    Giannone G; Glabman S; Burrows L; Schanzer H
    Mt Sinai J Med; 1983; 50(3):256-7. PubMed ID: 6604871
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites.
    Hobar PC; Turner WW; Valentine RJ
    Surgery; 1987 Feb; 101(2):161-4. PubMed ID: 3810487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneo-venous shunting. A clinico-pathological report.
    Tarin D; Vass AC; Kettlewell MG; Price JE
    Invasion Metastasis; 1984; 4(1):1-12. PubMed ID: 6735637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iatrogenic incarceration of umbilical hernia in cirrhotic patients with ascites.
    Chu KM; McCaughan GW
    Am J Gastroenterol; 1995 Nov; 90(11):2058-9. PubMed ID: 7485027
    [No Abstract]   [Full Text] [Related]  

  • 31. Denver peritoneovenous shunting for malignant or cirrhotic ascites. A prospective consecutive series.
    Söderlund C
    Scand J Gastroenterol; 1986 Dec; 21(10):1161-72. PubMed ID: 3809991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive hyperbilirubinemia complicating peritoneovenous shunting for malignant ascites.
    Gholson CF
    J Clin Gastroenterol; 1989 Apr; 11(2):236-7. PubMed ID: 2738363
    [No Abstract]   [Full Text] [Related]  

  • 33. Clarification on 'shunting malignant ascites'.
    Klopp A
    Am J Nurs; 1984 Oct; 84(10):1208. PubMed ID: 6567446
    [No Abstract]   [Full Text] [Related]  

  • 34. [Peritoneovenous shunt in the surgical treatment of ascites in patients with liver cirrhosis].
    Utíkal P; Král V; Bachleda P; Klein J
    Rozhl Chir; 1997 Oct; 76(10):497-501. PubMed ID: 9471741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peritoneovenous shunt in the treatment of ascites caused by a malignancy].
    Rietbroek RC; de Mulder PH; van Hoesel QG; Wobbes T
    Ned Tijdschr Geneeskd; 1991 Jun; 135(22):979-83. PubMed ID: 1712082
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
    Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary tumor embolization after peritoneovenous shunting for malignant ascites.
    Fildes J; Narvaez GP; Baig KA; Pai N; Gerst PH
    Cancer; 1988 May; 61(10):1973-6. PubMed ID: 3359399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of ascites with peritoneovenous shunting: a study of clinical management.
    Schumann D
    Heart Lung; 1983 May; 12(3):248-55. PubMed ID: 6551372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.